Vimarsana
Biggest News Aggregation in the World

Page 3 - David Ebsworth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Ebsworth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Ebsworth Today - Breaking & Trending Today

James Brady Joins Verona Pharma as Non-Executive Director - Vimarsana News

James Brady Joins Verona Pharma as Non-Executive Director

James Brady Joins Verona Pharma as Non-Executive Director - read this article along with other careers information, tips and advice on BioSpace

SYNLAB delivers record growth in Q1 2021 - Vimarsana News

SYNLAB delivers record growth in Q1 2021

SYNLAB delivers record growth in Q1 2021 Search jobs DGAP-News: SYNLAB AG / Key word(s): Quarter Results 12.05.2021 / 07:30 SYNLAB delivers record growth in Q1 2021 - Nearly doubling revenue (+96%) in Q1'21 at EUR 938 million - Strong SARS-CoV-2 testing volumes in Q1'21, above Q4'20 - Sustained underlying organic growth - Adjusted EBITDA multiplied by 3.8x at EUR 324 million, margin showing strong volume leverage - Record unlevered FCF of EUR 182 million driving major leverage ratio reduction at 2.3x, pre-IPO - M&A activity resuming, with 10 acquisitions completed year-to-date (~EUR 44 mil...

SYNLAB sets price range for its planned IPO at EUR 18.00 to EUR 23.00 per share - Vimarsana News

SYNLAB sets price range for its planned IPO at EUR 18.00 to EUR 23.00 per share

Disclaimer This release is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan. It does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Japan. The shares mentioned herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"). The shares may not be offered or sold in the United States, exc...

Source: dgap.de